<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: We investigated the prevalence of <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> as a hereditary cause of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> in the young Jamaican <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) population </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We identified patients aged 40 years or younger in whom primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> was diagnosed at the University Hospital of the West Indies from January 2004 to December 2008 </plain></SENT>
<SENT sid="2" pm="."><plain>We reviewed the medical records and <z:chebi fb="1" ids="51686">hematoxylin</z:chebi> and eosin (H&amp;E)-stained histopathology slides </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumour</z:e> blocks were tested for microsatellite instability (MSI) </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with MSI-high phenotype (MSI-H) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> had genetic counselling, after which genomic DNA was extracted from peripheral blood to test for MLH1 and MSH2 germline mutations </plain></SENT>
<SENT sid="5" pm="."><plain>Patients also had pedigree mapping </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: There were 25 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> aged 40 years or younger with no history of hereditary <z:hpo ids='HP_0003003'>colon cancer</z:hpo> syndrome </plain></SENT>
<SENT sid="7" pm="."><plain>The patients' mean age was 33 (range 21-40) years </plain></SENT>
<SENT sid="8" pm="."><plain>Histopathologic review confirmed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in <z:hpo ids='HP_0000001'>all</z:hpo> patients; 8 of 25 (32%) showed morphologic features suggestive of MSI </plain></SENT>
<SENT sid="9" pm="."><plain>We detected MSI-H in 5 of 23 (22%) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> blocks tested </plain></SENT>
<SENT sid="10" pm="."><plain>Review with H&amp;E staining correctly identified 80% of cases positive for MSI-H </plain></SENT>
<SENT sid="11" pm="."><plain>The false-positive rate and positive predictive value on H&amp;E review was 50% </plain></SENT>
<SENT sid="12" pm="."><plain>The negative predictive value of histomorphologic H&amp;E review was 94% </plain></SENT>
<SENT sid="13" pm="."><plain>Three patients were available for and had mutational analysis of DNA mismatch repair genes; 2 were positive for mutations in keeping with <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> and 1 had MLH1 alterations of uncertain significance </plain></SENT>
<SENT sid="14" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 3 met the Amsterdam criteria for hereditary nonpolyposis <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>CONCLUSION: Thirteen percent of the population had mutations in keeping with <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> </plain></SENT>
<SENT sid="16" pm="."><plain>This prevalence is similar to that reported for white populations </plain></SENT>
</text></document>